Imedex E-learning (audio)
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:41:03
- Mas informaciones
Informações:
Sinopsis
This webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patient- and provider-targeted education, formulary recommendations, and efforts to promote guideline concordant diabetes management.
